What if the future of MedTech isn't collecting more data—but finally connecting it?
In this episode of Med Tech Gurus, we talk with Plarent Ymeri, Founder and CEO of Smartiva, to explore how artificial intelligence is transforming post-market surveillance, quality management, and regulatory compliance by turning disconnected information into actionable intelligence.
Plarent explains why many medical device companies don't have a recall problem—they have a visibility problem. When complaints, risk files, field service, engineering, and regulatory data remain trapped in separate systems, organizations miss early warning signals that could improve patient safety and product performance. By connecting these data sources with AI, manufacturers can identify risk sooner, automate regulatory workflows, and make smarter decisions across the entire product lifecycle.
We also discuss AI-powered FDA Medical Device Reporting (MDR), scaling a healthcare software company, fundraising lessons, and why the best founders spend more time winning customers than chasing investors.
If you're interested in MedTech AI, post-market surveillance, FDA compliance, quality management systems, regulatory affairs, healthcare software, medical device safety, or healthcare innovation, this episode delivers a compelling vision for the future of intelligent MedTech.
